Silvercrest Asset Management Group LLC Curis Inc Transaction History

Silvercrest Asset Management Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $335,250 - $732,150	-45,000 Reduced 81.82%	10,000 $81,000
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $21,600 - $164,000	20,000 Added 57.14%	55,000 $450,000
Q3 2020 Nov 16, 2020	BUY	$0.95 - $1.42 $14,250 - $21,300	15,000 Added 75.0%	35,000 $41,000
Q1 2019 May 15, 2019	BUY	$0.78 - $2.01 $3,900 - $10,049	5,000 Added 33.33%	20,000 $40,000
Q4 2018 Feb 14, 2019	BUY	$0.62 - $2.25 $9,300 - $33,750	15,000 New	15,000 $10,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.